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Abstract
Background: Studies on the human myometrium have reported on different microarrays
containing different sets of genes or ESTs. However each study profiled only a small number of
patients due to various constraints. More profiling information would be an addition to our
knowledge base of parturition.
Methods: We compiled from five human studies, transcriptional differences between the non
pregnant myometrium (NP), preterm myometrium (PTNIL), term myometrium not in labor (TNIL)
and term myometrium in labor (TIL). Software modules developed by the Draghici's group at
Wayne State University (Detroit, MI, USA) were used to propose a hierarchical list of several
KEGG pathways most likely adjusted to changes observed in microarray experiments.
Results: The differential expression of 118 genes could be dispatched in 14 main KEGG pathways
that were the most representative of the changes seen in NP and PTNIL, versus TNIL or TIL.
Despite the potential of multiple pitfalls inherent to the use of the microarray technology, gene
module analysis of the myometrial transcriptome reveals the activation of precise signaling
pathways, some of which may have been under evaluated.
Conclusion: The remodelling and maturation processes that the uterus undergoes in pregnancy
appear clearly as phenomena which last during the full course of gestation. It is attested by the
nature of the main signaling pathways represented, in the comparison of the PTNIL versus TNIL
uterus. Comparatively, the onset of labor is a phenomenon which remains less well characterized
by these methods of analysis, possibly because it is a phenomenon occurring in too short a window
to have been grasped by the studies carried out up to now.
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Background
The common hallmark of recently published papers refer-
ring to functional genomics is their enthusiastic tone on
expectations. The near-entire genomic sequence of the
human and several model animals has given the opportu-
nity to flesh out the relationships between genes, pheno-
types and global transcriptional status at unprecedented
speed and scale [1]. The microarray technology allows the
examination of the function of thousands of genes at once
and in parallel, thereby providing an "assay" of the tran-
scriptional status of cells or tissues in a wide variety of
physiological or pathophysiological situations [2]. Com-
putational methods allow the identification of genes dif-
ferentially expressed across cell types, developmental
stages or pathological conditions; genes expressed in a
coordinated manner across a set of conditions and to
delineate clusters of genes sharing coherent expression
features [3]. These techniques open up new areas of unrec-
ognized molecular networks and yet unidentified players
in the anabolic-catabolic balance in intracellular signaling
cascades which have been so far hardly investigated in the
context of preterm labor.
From past studies in domestic animals, it has amply been
demonstrated that during pregnancy the production/
withdrawal of sex steroids, notably that of progesterone
which is thought to actively block the transformation of
the myometrium to a contractile phenotype, govern the
precise timing of labor onset [4]. Steroids modulate tran-
scription by interacting with specific response elements in
the promoter regions of target genes to recruit the basic
transcriptional complex. Although it is not yet definitively
established whether functional progesterone withdrawal
is indeed a pivotal event in the human parturition cascade
[5], all the preceding elements point to the fact that tran-
scriptome studies of the myometrium, fetal membranes
or placenta, should be a valuable approach to decipher
the mechanisms involved in human parturition. In the
course of the last 6 years, a number of transcriptomic stud-
ies on the preterm versus term pregnant human uterus [6-
12] or fetal membranes [13-17] have been published.
Studies on the human myometrium have reported on dif-
ferent microarrays containing different sets of genes or
ESTs. However each study profiled only a small number of
patients due to various constraints. More gene expression
profiling information would be an addition to our knowl-
edge base of parturition. We compiled from human stud-
ies [7-9,12,18], transcriptional differences between the
preterm myometrium (PTNIL), term myometrium not in
labor (TNIL) and term myometrium in labor (TIL).
Methods
To translate lists of hundreds of genes differentially regu-
lated in the conditions under study into a clearer under-
standing, we used combinations of searches through the
literature referenced in public databases (Table 1) and the
Onto-Tools software developed by the Draghici's group at
Wayne State University (Detroit, MI, USA) [19]. The
Onto-Express module helps to recognize functional pro-
files (using gene ontology terms) for the categories: bio-
chemical function; biological process; cellular role;
cellular component; molecular function, and chromo-
some location [20]. The Pathway-Express module helps
data mining – proposing on the basis of a computational
method a hierarchical list of several KEGG pathways
[21,22] most likely adjusted to changes observed in
microarray experiments [23,24]. KEGG is a knowledge
base for systematic analysis of gene functions, linking
genomic information with higher order functional infor-
mation [25]. Input data files for use with the Onto-Tools
software modules were built on gene lists reported in pub-
lished papers or, when available, on the complete gene
expression data set, deposited as supplemental data at a
public Internet site [7-9,12,18].
Results
Genomic studies of the uterus remain scarce and
accounted for approximately 1% of the total of genomic
studies published in the past 6 years. Studies in pregnancy
represented about 1/3 of the total studies on the uterus
and studies specifically dedicated to the myometrium
were even fewer (Figure 1).
In the myometrium, the differential expression of 118
genes could be distributed in 14 main KEGG pathways
that were the most representative of the changes seen in
NP versus TNIL, or PTNIL versus TNIL or TIL. It is to notice
that expression of genes involved in growth and cytoskel-
etal remodeling of myometrial cells was critically modi-
fied in the comparison of the non pregnant versus
pregnant uterus, until term. Conversely, limited changes
in gene transcription, characterized the transition between
the term and term in labor stages in the myometrium.
Interestingly, genes involved in apoptosis were only
expressed in advanced gestation and their changes clearly
anticipated the onset of labor (Table 2).
Table 3 lists the genes expressed in the uterus for the
MAPK signaling pathway which is a good example of a
pathway whose changes remain active until the end of
pregnancy. An overall picture of the general trend of
changes in gene expression pertaining to the 14 KEGG
pathways that characterize the transition of the preterm
versus term uterus is summarized in Figure 2.
Discussion
Drawbacks and limitations inherent to the use of Onto-
Tools or of their cognate alternatives for ontological anal-
ysis have been discussed. These limitations remain to the
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present day, questions over the robustness of array data
and the criteria under which their conclusions were drawn
have been made [23]. A recent review by Allison et al. [26],
has the merit of proposing simple sound recommenda-
tions for future microarrays analysis methods.
Despite the potential of pitfalls inherent to the use of the
microarray technology (review in [27]), gene module
analysis of the myometrial transcriptome reveals the acti-
vation of precise signaling pathways, some of which may
have been under evaluated. Thus, the remodelling and
maturation processes that the uterus undergoes in preg-
nancy appear clearly as phenomena which last during the
full course of gestation. It is attested by the nature of the
main signaling pathways represented, in the comparison
of the PTNIL versus TNIL uterus. Comparatively, the onset
of labor is a phenomenon which remains less well
described by these methods of analysis, possibly because
it is a phenomenon occurring in too short a window to
have been grasped by the few studies carried out up to
now.
Also, although the myometrium is considered to be a rel-
atively homogeneous tissue, some of its largest changes at
term occurred in genes that were not normally associated
with muscle. This is consistent with animal studies which
better allow to explore the global pattern of gene expres-
sion and their co-regulation on the basis of their genomic
location over the full time-course of myometrial transfor-
mation or following experimentally-controlled infection
[28-31].
Today, a main handicap with high throughput methods is
the capacity for each individual research group to handle
samples and data. These methods indeed suggested a
number of potentially new biochemical markers of pre-
term labor [32], some of which, for example, could be
detected in circulating immune-cells. However, all stud-
ies, notably in the human, have suffered from several lim-
itations, among which are the limited size of samples
which hardly can be considered as representative of even
a small population; the regular inconsistency in nomen-
clature usage or terminology in reference to the molecules
studied; the lack of integrated databases to compile differ-
ent studies and the underestimation of heterogeneity of
the tissue exposed to the microarray analysis.
Number of articles referring to functional genomics in the PubMed dat base, years 2000 to 2005 [35]Figur  1
Number of articles referring to functional genomics 
in the PubMed database, years 2000 to 2005 [35]. 
Keywords for search strategy (limits: human): functional 
genomics OR microarray, (black squares); (functional genom-
ics OR microarray) AND uterus (closed grey circles); (func-
tional genomics OR microarray) AND uterus AND pregnant 
(open white circles); (functional genomics OR microarray) 
AND uterus AND myometrium (open white diamonds). On 
the graph, the number of papers is divided by 100 for the 
total papers on functional genomics OR microarray (black 
squares).
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Table 1: Studies used to compile the differential expression of the genes in the myometrium
Author reference Platform Number of genes on chip Supplemental data, where? Comparison
Rehman et al., [9] Incyte Genomics UniGEM V microarray Version 1.0 7,075 cDNA - Yes (raw data)
- # GSM 6791 NCBI GEO (from 2005)
NP-TNIL
Bethin et al., [8] Affymetrix HG-U95A chips U95 set, approx. 10,000 genes (oligo) - Yes
- PDF files
- no open access
PTNIL-TNIL
Charpigny et al., [7] Clontech Atlas Human 1.2 & 1.2II 2,352 cDNA - Yes (raw data)
- XLS files
- Lab., open access
PTNIL-TNIL
Esplin et al., [18] Unspecified 6,912 cDNA in duplicate - Yes (raw data)
- XLS files
- Lab., open access
TNIL-TIL
Havelock et al., [12] Incyte Genomics UniGEM V microarray Version 2.0 9,182 cDNA - No TNIL-TIL
NP-TNIL, Non-pregnant (NP) versus term not in labor myometrium (TNIL); PTNIL-TNIL, preterm not in labor (PTNIL) versus TNIL myometrium; 
TNIL-TIL, TNIL versus term in labor myometrium (TIL).
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Conclusion
Genomic studies of the pregnant uterus, like in other
domains, widen our comprehension of the structural and
metabolic transformations which affect the myometrium
from the beginning of pregnancy until parturition.
Although the studies so far published remain a few num-
bers, they throw light on the urgent need to constitute a
Working Group to standardize the techniques, terminol-
ogy and experimental plans as well as to design new inte-
grated databasing protocols. In this respect we have much
to learn from those who anticipated the burst of genome
biology [33]. Access to dedicated databases by researchers
and clinicians will be critical to progress in biomarker
identification for the major obstetrical concern, namely
the preterm birth.
List of abbreviations
CAMs, cell adhesion molecules; ECM, extra-cellular
matrix; ESTs, expressed sequence tags; GF, growth factors;
GPCR, G-protein coupled membrane receptors; JAK/
STAT, Janus kinases/Signal transducers and activators of
transcription; KEGG, Kyoto Encyclopedia of Genes and
Table 3: The MAPK signaling pathway differentially expressed in the myometrium
MAPK signaling pathway
NP-TNIL1 (15) PTNIL-TNIL2 (12) TNIL-TIL3 (4)
CD14(+) EGF(+) BDNF(+)
EGFR(+) IKBKB(+) DUSP5(+)
FGFR1(+) MAP2K4(+) NR4A1(+)
FLNA(+) MAPK10(+) TGFB2(+)
HSPA5(+) PLA2G5(+)
HSPA8(+) RAP1A(+)
MAP3K5(+) RASA1(+)
NLK(+) TNF(+)
PLA2G2A(+) TP53(+)
PRKCB1(+) PLA2G2A(-)
PRKCG(+) PPP5C(-)
RAC2(+) TNFRSF6(-)
RASGRP2(+)
RRAS(+)
YWHAZ(+)
Genes detected in genomic studies according to 1NP-TNIL, to 2PTNIL-TNIL or to 3TNIL-TIL comparisons, during the cycle or pregnancy. Brackets: 
number of genes represented in the pathway. All gene transcripts showed at least a 2-fold or more, up (+) or down-regulation (-) after paired 
comparisons of the following stages: non-pregnant (NP) versus term not in labor (TNIL), preterm (PTNIL) versus TNIL, or TNIL versus term in 
labor (TIL). OMIM nomenclature [34] adopted for gene names.
Table 2: The main KEGG metabolic pathways, regulatory pathways or molecular complexes expressed in the myometrium
KEGG pathways1 NP-TNIL PTNIL-TNIL TNIL-TIL
Actin cytoskeleton 15 6 0
Focal adhesion 18 6 3
Adherens junctions 11 3 0
Tight junctions 10 0 0
Cytokines-cytokine receptors 8 12 5
Toll-like receptors 5 6 1
TGF-beta signaling 6 2 3
Wnt signaling 7 2 1
MAPK signaling 15 12 4
Phosphatidylinositol signaling 5 8 0
JAK/STAT signaling 6 7 1
Apoptosis 0 6 0
Calcium signaling 8 8 0
Neuroactive ligand-receptors 6 6 0
1A detailed description of KEGG pathways is accessible at [25]. For each pathway, gene transcripts showed at least a 2 fold or more, up or down-
regulation after paired comparisons of the following stages: non-pregnant (NP) versus term not in labor myometrium (TNIL), preterm (PTNIL) 
versus TNIL myometrium, or TNIL versus term in labor myometrium (TIL). Number of genes represented in a defined pathway. A total of 118 
differentially expressed genes (genes may belong to several pathways) were detected, 0: no gene represented for the corresponding pathway.
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Genomes; MAPK, mitogen-activated protein kinase; NP,
non pregnant; OMIM, Online Mendelian Inheritance in
Man; PTNIL, preterm not in labor; TGF, transforming
growth factor; TIL, term myometrium in labor; TNIL, term
not in labor; Wnt protein/signaling, wingless-type pro-
tein/signaling. Gene names, see [34] for detailed names of
genes listed in this article.
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